PTEN and breast carcinoma: Studies had shown that degrading PTEN through lysosome-mediated activation of PI3K/AKT/GSK3β/SNAI1 signaling pathway could promote the metastasis and progression of EMT and breast cancer tumors, which showed that the loss of PTEN contributed to the development of breast cancer [33].